STEADY-STATE PHARMACOKINETICS OF PIROXICAM IN CHILDREN WITH RHEUMATIC DISEASES

被引：11
作者：
MAKELA, AL
OLKKOLA, KT
MATTILA, MJ
机构：
[1] UNIV HELSINKI,DEPT CLIN PHARMACOL,SF-00170 HELSINKI 17,FINLAND
[2] UNIV TURKU,CENT HOSP,DEPT PEDIAT,SF-20520 TURKU 52,FINLAND
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1991年 / 41卷 / 01期
关键词：
PIROXICAM; PHARMACOKINETICS; CHILDREN; RHEUMATOID ARTHRITIS;
D O I：
10.1007/BF00280114
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Ten children with rheumatoid arthritis, aged 7-16 y and weighing 20-63 kg, were treated with piroxicam mean dose 0.4 mg . kg-1 once daily for 2 weeks. On Day 15, blood was sampled from 2-120 h after the last dose. The C(max) for piroxicam ranged from 3.6 to 9.8 (mean 6.6) mg . l-1 and its half-life by log linear computation was 22 to 40 (mean 32.6) h. The volumes of distribution and the total body clearance were estimated as the ratio of actual volumes of distribution and actual clearances to availability. The volumes of distribution (V/F) were 0.12 to 0.25 (mean 0.16) l . kg-1, and the total body clearances (CL/F) were 2.1 to 5.0 (mean 3.4) ml . kg-1 . h-1. Thus, piroxicam clearance in these patients was higher and its half-life was shorter than those previously reported in young adults, yet V appeared similar.
引用
收藏
页码：79 / 81
页数：3
相关论文
共 50 条
  • [1] Steady-State Pharmacokinetics of Intravenous Levetiracetam in Neurocritical Care Patients
    Spencer, Dustin D.
    Jacobi, Judith
    Juenke, JoEtta M.
    Fleck, James D.
    Kays, Michael B.
    PHARMACOTHERAPY, 2011, 31 (10): : 934 - 941
  • [2] Effect of omeprazole on the steady-state pharmacokinetics of voriconazole
    Wood, N
    Tan, K
    Purkins, L
    Layton, G
    Hamlin, J
    Kleinermans, D
    Nichols, D
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 : 56 - 61
  • [3] THEOPHYLLINE STEADY-STATE PHARMACOKINETICS IS NOT ALTERED BY OMEPRAZOLE
    TABURET, AM
    GENEVE, J
    BOCQUENTIN, M
    SIMONEAU, G
    CAULIN, C
    SINGLAS, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (03) : 343 - 345
  • [4] Effect of exenatide on the steady-state pharmacokinetics of digoxin
    Kothare, PA
    Soon, DKW
    Linnebjerg, H
    Park, S
    Chan, C
    Yeo, A
    Lim, M
    Mace, KE
    Wise, SD
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09) : 1032 - 1037
  • [5] STEADY-STATE PHARMACOKINETICS OF DOPAMINE IN ADULT PATIENTS
    LECORRE, P
    MALLEDANT, Y
    TANGUY, M
    LEVERGE, R
    CRITICAL CARE MEDICINE, 1993, 21 (11) : 1652 - 1657
  • [6] Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin
    Ayalasomayajula, Surya P.
    Vaidyanathan, Sujata
    Kemp, Charisse
    Prasad, Pratapa
    Balch, Alfred
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (05) : 613 - 619
  • [7] Single-dose and steady-state pharmacokinetics of a new oral suspension of ciprofloxacin in children
    Peltola, H
    Ukkonen, P
    Saxén, H
    Stass, H
    PEDIATRICS, 1998, 101 (04) : 658 - 662
  • [8] Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients
    Cerqueira, PM
    Cesarino, EJ
    Mateus, FH
    Mere, Y
    Santos, SRCJ
    Lanchote, VL
    CHIRALITY, 1999, 11 (07) : 591 - 597
  • [9] Voriconazole does not affect the steady-state pharmacokinetics of digoxin
    Purkins, L
    Wood, N
    Kleinermans, D
    Nichols, D
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 : 45 - 50
  • [10] STEADY-STATE PHARMACOKINETICS OF IDEBENONE IN HEALTHY-VOLUNTEERS
    BONI, J
    MAUGERI, A
    ZINGALI, G
    RAMELLI, L
    GHERARDI, S
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1992, 15 (03) : 197 - 205
12345